ThriveRx Contributes to Resource Paper on Nutrition Support at School
CINCINNATI, Ohio — Aug. 29, 2017— Collaborative paper by author group including employees of ThriveRx, a division of Diplomat Specialty Infusion Group, outlines needs of children on nutrition support in educational environments.
ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, has contributed to a report in Nutrition in Clinical Practice, an official journal of the American Society for Parenteral and Enteral Nutrition (ASPEN).
“Resources for the Provision of Nutrition Support to Children in Educational Environments” explores the complex care needs of children on nutrition support as they grow and enter the educational setting.
“We couldn’t be any prouder of our consumer advocates, Ann and Victoria, being a part of the collaborative specialty report with ASPEN,” said Phil Rielly, Diplomat vice president and president of Diplomat Specialty Infusion Group. “This paper affirms what we’ve long believed: the importance of empowering those on home parenteral and enteral nutrition. We’re excited to have had the opportunity to partner with ASPEN in creating a useful resource our consumers can rely on. We look forward to future collaboration to improve patient care.”
The report aims to raise awareness and provide education resources for those involved in supervising and providing nutrition support for children at school.
“It was such a great experience working with consumer advocates at ThriveRx to develop this resource,” said Peggi Guenter, senior director of clinical practice, quality, and advocacy at ASPEN. “Especially as children go back to school, it’s important that they and their families feel well-prepared and supported as they integrate their nutrition needs with the classroom.”
The paper outlines suggested roles and responsibilities for those involved with nutrition support care. However, all interventions and routine care must align with physician orders, school nurse privileges and competencies, and state and local regulations.
Co-authors include Mandy Corrigan, Shirley Huang, Ann Weaver, David Keeler, Katina Rahe, Jane Balint, Michelle Marti, Brandis Goodman, Traci Nagy, Victoria DeLano, and Betty Bond.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat’s filings with the Securities and Exchange Commission, including “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended Dec. 31, 2016, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.
Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
The American Society for Parenteral and Enteral Nutrition (ASPEN) is dedicated to improving patient care by advancing the science and practice of nutrition support therapy and metabolism. Founded in 1976, ASPEN is an interdisciplinary organization whose members are involved in the provision of clinical nutrition therapies, including parenteral and enteral nutrition. With more than 6,500 members from around the world, ASPEN is a community of dietitians, nurses, nurse practitioners, pharmacists, physicians, scientists, students, and other health professionals from every facet of nutrition support clinical practice, research, and education. For more information about ASPEN, please visit nutritioncare.org.
Kali Lucas, Public Relations Specialist
810.768.9580 | email@example.com
Deb Pfister, ThriveRx
978.501.0801 | firstname.lastname@example.org
@DiplomatRx@BuntyLUFC We appreciate you reaching out. Would you mind direct messaging us so we can help?4 days ago
@DiplomatRxOur Navigating Patient Engagement webinar is available on demand. Sign up at https://t.co/LN1qWkrCZp to watch the r… https://t.co/RaQGhk3xF74 days ago
@SpecialtyPharmRT @SpecialtyPharm: Specialty Pharmacies Earn High Marks in First NASP Patient Satisfaction @Rx_Specialty Survey #NASP2017 https://t.co/B0k…4 days ago
@DiplomatRxDid you miss yesterday's Navigating Patient Engagement webinar? If so, register below to view it on demand.… https://t.co/SHcloxFFXP2 weeks ago
@DiplomatRx"We're going live today with our new pharma webinar! Tune in at 12 p.m. ET at the link below."—Cheryl Allen… https://t.co/6ejXSvYDKA2 weeks ago